Cytokinetics Inc (CYTK)
Net profit margin
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net income (ttm) | US$ in thousands | -589,526 | -576,402 | -545,279 | -530,598 | -524,396 | -518,961 | -565,718 | -465,847 | -437,439 | -336,548 | -236,455 | -269,243 | -215,314 | -228,674 | -155,763 | -134,989 | -127,290 | -114,000 | -140,398 | -131,731 |
| Revenue (ttm) | US$ in thousands | 18,474 | 3,219 | 3,134 | 3,752 | 7,530 | 7,815 | 9,952 | 98,053 | 94,588 | 148,231 | 151,153 | 65,028 | 70,428 | 21,550 | 57,801 | 58,551 | 55,828 | 54,318 | 18,685 | 22,229 |
| Net profit margin | -3,191.11% | -17,906.24% | -17,398.82% | -14,141.74% | -6,964.09% | -6,640.58% | -5,684.47% | -475.10% | -462.47% | -227.04% | -156.43% | -414.04% | -305.72% | -1,061.13% | -269.48% | -230.55% | -228.00% | -209.88% | -751.39% | -592.61% |
December 31, 2024 calculation
Net profit margin = Net income (ttm) ÷ Revenue (ttm)
= $-589,526K ÷ $18,474K
= -3,191.11%
The net profit margin of Cytokinetics Inc has shown a consistent trend of being negative over the provided periods from March 31, 2020, to December 31, 2024. The net profit margin is a metric that indicates the percentage of each dollar of revenue that results in net profit after all expenses have been deducted.
During this period, the company experienced significant fluctuations in its net profit margin, ranging from -592.61% to -17,906.24%. These negative values indicate that the company's expenses exceeded its revenue, resulting in losses.
It is noteworthy that the net profit margin deteriorated significantly in the later periods, with margins dropping well below -1,000% in the last three quarters of 2023 and remaining highly negative in the first two quarters of 2024.
Overall, the consistently negative net profit margins suggest that Cytokinetics Inc has not been able to generate sufficient profits relative to its revenue, indicating financial challenges and potential inefficiencies in its operations during the analyzed periods.
Peer comparison
Dec 31, 2024